NGS-based cancer sequencing methods provide more information in less time compared to single-gene and array-based approaches.
Access a broad range of fixed and custom next-generation sequencing panels targeting known cancer-related gene variants.
Our sequencing and microarray technologies support a broad range of cancer genomics research applications, from DNA to RNA analysis, epigenetics, and more.